nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Hypotension symptomatic—Ramipril—type 1 diabetes mellitus	0.171	0.178	CcSEcCtD
Regadenoson—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0589	0.0612	CcSEcCtD
Regadenoson—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.037	0.0384	CcSEcCtD
Regadenoson—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0228	0.0237	CcSEcCtD
Regadenoson—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0227	0.0236	CcSEcCtD
Regadenoson—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.022	0.0229	CcSEcCtD
Regadenoson—Asthma—Ramipril—type 1 diabetes mellitus	0.0186	0.0194	CcSEcCtD
Regadenoson—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.0183	0.0191	CcSEcCtD
Regadenoson—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.0182	0.0189	CcSEcCtD
Regadenoson—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.0179	0.0186	CcSEcCtD
Regadenoson—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0164	0.017	CcSEcCtD
Regadenoson—Renal failure—Ramipril—type 1 diabetes mellitus	0.0163	0.017	CcSEcCtD
Regadenoson—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0163	0.0169	CcSEcCtD
Regadenoson—Adenosine triphosphate—ABCC8—type 1 diabetes mellitus	0.0159	1	CrCbGaD
Regadenoson—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.0147	0.0152	CcSEcCtD
Regadenoson—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0139	0.0145	CcSEcCtD
Regadenoson—Flushing—Ramipril—type 1 diabetes mellitus	0.0138	0.0144	CcSEcCtD
Regadenoson—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0135	0.014	CcSEcCtD
Regadenoson—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.0134	0.014	CcSEcCtD
Regadenoson—Mental disorder—Ramipril—type 1 diabetes mellitus	0.0131	0.0136	CcSEcCtD
Regadenoson—Erythema—Ramipril—type 1 diabetes mellitus	0.013	0.0135	CcSEcCtD
Regadenoson—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0127	0.0132	CcSEcCtD
Regadenoson—Tremor—Ramipril—type 1 diabetes mellitus	0.0122	0.0127	CcSEcCtD
Regadenoson—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.0121	0.0125	CcSEcCtD
Regadenoson—Angioedema—Ramipril—type 1 diabetes mellitus	0.0119	0.0123	CcSEcCtD
Regadenoson—Malaise—Ramipril—type 1 diabetes mellitus	0.0117	0.0122	CcSEcCtD
Regadenoson—Syncope—Ramipril—type 1 diabetes mellitus	0.0116	0.0121	CcSEcCtD
Regadenoson—Palpitations—Ramipril—type 1 diabetes mellitus	0.0115	0.0119	CcSEcCtD
Regadenoson—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.0114	0.0119	CcSEcCtD
Regadenoson—Cough—Ramipril—type 1 diabetes mellitus	0.0113	0.0118	CcSEcCtD
Regadenoson—Convulsion—Ramipril—type 1 diabetes mellitus	0.0113	0.0117	CcSEcCtD
Regadenoson—Chest pain—Ramipril—type 1 diabetes mellitus	0.0111	0.0115	CcSEcCtD
Regadenoson—Myalgia—Ramipril—type 1 diabetes mellitus	0.0111	0.0115	CcSEcCtD
Regadenoson—Arthralgia—Ramipril—type 1 diabetes mellitus	0.0111	0.0115	CcSEcCtD
Regadenoson—Anxiety—Ramipril—type 1 diabetes mellitus	0.011	0.0115	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.011	0.0114	CcSEcCtD
Regadenoson—Discomfort—Ramipril—type 1 diabetes mellitus	0.0109	0.0114	CcSEcCtD
Regadenoson—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.0106	0.011	CcSEcCtD
Regadenoson—Shock—Ramipril—type 1 diabetes mellitus	0.0104	0.0108	CcSEcCtD
Regadenoson—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.0104	0.0108	CcSEcCtD
Regadenoson—Tachycardia—Ramipril—type 1 diabetes mellitus	0.0103	0.0108	CcSEcCtD
Regadenoson—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0103	0.0107	CcSEcCtD
Regadenoson—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.0102	0.0107	CcSEcCtD
Regadenoson—Hypotension—Ramipril—type 1 diabetes mellitus	0.0099	0.0103	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00966	0.01	CcSEcCtD
Regadenoson—Insomnia—Ramipril—type 1 diabetes mellitus	0.00959	0.00997	CcSEcCtD
Regadenoson—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00952	0.0099	CcSEcCtD
Regadenoson—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00945	0.00983	CcSEcCtD
Regadenoson—Somnolence—Ramipril—type 1 diabetes mellitus	0.00942	0.0098	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00915	0.00952	CcSEcCtD
Regadenoson—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00873	0.00908	CcSEcCtD
Regadenoson—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00867	0.00901	CcSEcCtD
Regadenoson—Urticaria—Ramipril—type 1 diabetes mellitus	0.00842	0.00876	CcSEcCtD
Regadenoson—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00838	0.00871	CcSEcCtD
Regadenoson—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00781	0.00812	CcSEcCtD
Regadenoson—Asthenia—Ramipril—type 1 diabetes mellitus	0.0076	0.00791	CcSEcCtD
Regadenoson—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00725	0.00754	CcSEcCtD
Regadenoson—Dizziness—Ramipril—type 1 diabetes mellitus	0.00701	0.00729	CcSEcCtD
Regadenoson—Vomiting—Ramipril—type 1 diabetes mellitus	0.00674	0.00701	CcSEcCtD
Regadenoson—Rash—Ramipril—type 1 diabetes mellitus	0.00668	0.00695	CcSEcCtD
Regadenoson—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00668	0.00694	CcSEcCtD
Regadenoson—Headache—Ramipril—type 1 diabetes mellitus	0.00664	0.00691	CcSEcCtD
Regadenoson—Nausea—Ramipril—type 1 diabetes mellitus	0.0063	0.00655	CcSEcCtD
Regadenoson—ADORA2A—Monoamine Transport—IL1R1—type 1 diabetes mellitus	0.00235	0.104	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—NOS1—type 1 diabetes mellitus	0.00142	0.063	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—CHRM2—type 1 diabetes mellitus	0.000912	0.0404	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—PAX4—type 1 diabetes mellitus	0.000798	0.0354	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—IAPP—type 1 diabetes mellitus	0.000598	0.0265	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—IL1B—type 1 diabetes mellitus	0.00058	0.0257	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.000539	0.0239	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—ADRB1—type 1 diabetes mellitus	0.000522	0.0232	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—GCG—type 1 diabetes mellitus	0.000468	0.0207	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—CCR5—type 1 diabetes mellitus	0.000433	0.0192	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—ITPR3—type 1 diabetes mellitus	0.000426	0.0189	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—TNF—type 1 diabetes mellitus	0.000421	0.0186	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000396	0.0176	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000365	0.0162	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000361	0.016	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000361	0.016	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000339	0.015	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—ITPR3—type 1 diabetes mellitus	0.000327	0.0145	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—VAV1—type 1 diabetes mellitus	0.000291	0.0129	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.000291	0.0129	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.000278	0.0123	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.000275	0.0122	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.000275	0.0122	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000258	0.0115	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD86—type 1 diabetes mellitus	0.000254	0.0113	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00025	0.0111	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000249	0.011	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB3—type 1 diabetes mellitus	0.000229	0.0102	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—VAV1—type 1 diabetes mellitus	0.000224	0.00993	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000217	0.00962	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000208	0.00921	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.0002	0.00888	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CD86—type 1 diabetes mellitus	0.000195	0.00866	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000195	0.00863	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000191	0.00844	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00019	0.00841	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000188	0.00834	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD80—type 1 diabetes mellitus	0.000185	0.00821	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—ERBB3—type 1 diabetes mellitus	0.000176	0.00781	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00017	0.00753	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000161	0.00714	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000158	0.00702	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000157	0.00696	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—type 1 diabetes mellitus	0.000156	0.00693	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000155	0.00688	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000146	0.00647	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000143	0.00632	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CD80—type 1 diabetes mellitus	0.000143	0.00632	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000141	0.00625	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000141	0.00625	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000133	0.00588	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000131	0.00581	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000123	0.00544	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000123	0.00543	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.00012	0.00533	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000119	0.00528	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000111	0.00494	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.00011	0.00485	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000108	0.00477	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000107	0.00475	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.0001	0.00444	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	9.96e-05	0.00441	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	9.78e-05	0.00433	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	9.73e-05	0.00431	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	9.6e-05	0.00425	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	9.24e-05	0.00409	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	8.97e-05	0.00398	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	8.95e-05	0.00396	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	8.71e-05	0.00386	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	8.43e-05	0.00373	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—STAT3—type 1 diabetes mellitus	8.42e-05	0.00373	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	8.39e-05	0.00372	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	8.33e-05	0.00369	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	8.33e-05	0.00369	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	8.15e-05	0.00361	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	8.12e-05	0.0036	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	7.83e-05	0.00347	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—type 1 diabetes mellitus	7.8e-05	0.00346	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—EGFR—type 1 diabetes mellitus	7.66e-05	0.00339	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	7.65e-05	0.00339	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	7.03e-05	0.00312	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	6.94e-05	0.00307	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	6.84e-05	0.00303	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	6.62e-05	0.00293	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	6.58e-05	0.00292	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	6.58e-05	0.00292	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	6.3e-05	0.00279	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	6.21e-05	0.00275	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—IL6—type 1 diabetes mellitus	5.88e-05	0.00261	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SST—type 1 diabetes mellitus	5.78e-05	0.00256	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	5.75e-05	0.00255	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	5.15e-05	0.00228	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.95e-05	0.0022	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.81e-05	0.00213	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.8e-05	0.00213	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.37e-05	0.00194	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.36e-05	0.00193	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.2e-05	0.00186	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.01e-05	0.00178	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.98e-05	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.78e-05	0.00168	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.72e-05	0.00165	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.67e-05	0.00163	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.64e-05	0.00161	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.06e-05	0.00136	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—INS—type 1 diabetes mellitus	2.89e-05	0.00128	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.8e-05	0.00124	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.78e-05	0.00123	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.58e-05	0.00115	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.54e-05	0.00112	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.15e-05	0.000954	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.15e-05	0.000953	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.14e-05	0.000948	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.81e-05	0.000802	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.64e-05	0.000729	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.26e-05	0.00056	CbGpPWpGaD
